Greenwich LifeSciences

GLSINasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$210.779 M

$14.36 +0.84%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$19.4M

Loss-making

Shares outstanding

14,678,208

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#262AN2 TherapeuticsANTX$213.6M
#263Atrium TherapeuticsRNA$211.1M
#264Greenwich LifeSciencesGLSI$210.8M
#265Arcturus TherapeuticsARCT$210.6M
#266Satellos BioscienceMSLE$208.9M

Where these numbers come from

Share counts and financials for Greenwich LifeSciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.